Takayuki Kanaseki

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications

An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancer.

An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancer.

Journal: Oncoimmunology
Published: July 09, 2025

Immunopeptidomics combined with full-length transcriptomics uncovers diverse neoantigens.

Immunopeptidomics combined with full-length transcriptomics uncovers diverse neoantigens.

Journal: Cell reports
Published: May 19, 2025

Characteristic TARC/CCL17 expression in the salivary gland of IgG4-related disease: potential diagnostic utility and insights into pathogenesis.

Characteristic TARC/CCL17 expression in the salivary gland of IgG4-related disease: potential diagnostic utility and insights into pathogenesis.

Journal: Immunological medicine
Published: February 04, 2025

The size of CD8+ infiltrating T cells is a prognostic marker for esophageal squamous cell carcinoma.

The size of CD8+ infiltrating T cells is a prognostic marker for esophageal squamous cell carcinoma.

Journal: Scientific reports
Published: December 17, 2024

Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment.

Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment.

Journal: Science translational medicine
Published: December 04, 2024

Effect of human survivin-2B-specific cytotoxic CD8+ T lymphocytes on CD44+/- HSC-2 and HSC-3 oral cancer cells.

Effect of human survivin-2B-specific cytotoxic CD8+ T lymphocytes on CD44+/- HSC-2 and HSC-3 oral cancer cells.

Journal: European journal of oral sciences
Published: November 28, 2024

Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization.

Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization.

Journal: Human vaccines & immunotherapeutics
Published: November 14, 2024

HLA class II neoantigen presentation for CD4+ T cell surveillance in HLA class II-negative colorectal cancer.

HLA class II neoantigen presentation for CD4+ T cell surveillance in HLA class II-negative colorectal cancer.

Journal: Oncoimmunology
Published: November 07, 2024

Loss of Tapasin in Tumors Potentiates T-Cell Recognition and Anti-Tumor Effects of Immune Checkpoint Blockade.

Loss of Tapasin in Tumors Potentiates T-Cell Recognition and Anti-Tumor Effects of Immune Checkpoint Blockade.

Journal: Cancer science
Published: October 28, 2024

Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes.

Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes.

Journal: Science advances
Published: September 18, 2024

MHC class I trafficking signal improves induction of cytotoxic T lymphocyte using artificial antigen presenting cells.

MHC class I trafficking signal improves induction of cytotoxic T lymphocyte using artificial antigen presenting cells.

Journal: Biochemistry and biophysics reports
Published: September 11, 2024

Neoantigen prioritization based on antigen processing and presentation.

Neoantigen prioritization based on antigen processing and presentation.

Journal: Frontiers in immunology
Published: August 28, 2024
Showing 1-12 of 119

Last Updated: 09/26/2026